CIBC Private Wealth Group’s Trinity Biotech TRIB Stock Holding History

CIBC Private Wealth Group’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$176	Hold	222	–	–	﹤0.01%	3244
2025 Q3	$231	Hold	222	–	–	﹤0.01%	2941
2025 Q2	$144	Hold	222	–	–	﹤0.01%	2940
2025 Q1	$115	Hold	222	–	–	﹤0.01%	2984
2024 Q4	$191	Hold	222	–	–	﹤0.01%	2894
2024 Q3	$244	Hold	222	–	–	﹤0.01%	3014
2024 Q2	$475	Hold	222	–	–	﹤0.01%	2982
2024 Q1	$433	Buy	+222	New	+$520	﹤0.01%	2946

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group's TRIB Position: Q4 2025 in Review

CIBC Private Wealth Group held its Trinity Biotech (TRIB) position steady in Q4 2025 at 222 shares worth $176. The position accounts for ﹤0.01% of the portfolio, ranked #3244.

CIBC Private Wealth Group first reported a position in TRIB in Q1 2024 and has held it in 8 quarters since. The position peaked at $475 in Q2 2024. 27 funds tracked by Wall St. Rank hold TRIB as of Q4 2025.

CIBC Private Wealth Group held 222 shares of Trinity Biotech worth $176 as of Q4 2025.
CIBC Private Wealth Group left its Trinity Biotech share count unchanged in Q4 2025.
Trinity Biotech made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3244 holding.
CIBC Private Wealth Group first reported a position in Trinity Biotech in Q1 2024 and has held it in 8 quarters since.
CIBC Private Wealth Group's Trinity Biotech position peaked at $475 in Q2 2024.
27 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.